Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) EBIT Margin (2021 - 2025)

Beauty Health (SKIN) has disclosed EBIT Margin for 5 consecutive years, with 8.83% as the latest value for Q3 2025.

  • On a quarterly basis, EBIT Margin rose 1847.0% to 8.83% in Q3 2025 year-over-year; TTM through Sep 2025 was 9.31%, a 1340.0% increase, with the full-year FY2024 number at 20.27%, up 1262.0% from a year prior.
  • EBIT Margin was 8.83% for Q3 2025 at Beauty Health, down from 3.45% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 2.49% in Q4 2022 to a low of 84.28% in Q3 2023.
  • A 5-year average of 17.28% and a median of 11.19% in 2023 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: plummeted -7938bps in 2023, then skyrocketed 5698bps in 2024.
  • Beauty Health's EBIT Margin stood at 9.65% in 2021, then soared by 74bps to 2.49% in 2022, then tumbled by -660bps to 18.96% in 2023, then surged by 55bps to 8.57% in 2024, then fell by -3bps to 8.83% in 2025.
  • Per Business Quant, the three most recent readings for SKIN's EBIT Margin are 8.83% (Q3 2025), 3.45% (Q2 2025), and 17.28% (Q1 2025).